[go: up one dir, main page]

TR201000948A1 - Aripiprazol formülasyonları. - Google Patents

Aripiprazol formülasyonları.

Info

Publication number
TR201000948A1
TR201000948A1 TR2010/00948A TR201000948A TR201000948A1 TR 201000948 A1 TR201000948 A1 TR 201000948A1 TR 2010/00948 A TR2010/00948 A TR 2010/00948A TR 201000948 A TR201000948 A TR 201000948A TR 201000948 A1 TR201000948 A1 TR 201000948A1
Authority
TR
Turkey
Prior art keywords
aripiprazole formulations
aripiprazole
aripiprazole monohydrate
formulations
formulation
Prior art date
Application number
TR2010/00948A
Other languages
English (en)
Inventor
Toksöz Ahmet
Ümi̇t Çi̇fter Musa
Mesut Burcu
Pehli̇van Akalin Nur
Demi̇r Vi̇ldan
Türkyilmaz Ali̇
Original Assignee
Sanovel İlaç San.Ve Ti̇c.A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San.Ve Ti̇c.A.Ş. filed Critical Sanovel İlaç San.Ve Ti̇c.A.Ş.
Priority to TR2010/00948A priority Critical patent/TR201000948A1/tr
Priority to PL11153639T priority patent/PL2359816T3/pl
Priority to EP11153639.7A priority patent/EP2359816B1/en
Priority to ES11153639.7T priority patent/ES2607440T3/es
Publication of TR201000948A1 publication Critical patent/TR201000948A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Buluş farmasötik bir formülasyon olup özelliği, aripiprazol monohidrat ile süper dağıtıcı ve dağıtıcı karışımı içermesi ile karakterize edilmektedir. Daha da özel olarak buluş aripiprazol monohidratın yüksek çözünürlüğe ve çözünme hızına, dolayısı ile yüksek biyoyararlanıma sahip formülasyonu ile ilgilidir.
TR2010/00948A 2010-02-09 2010-02-09 Aripiprazol formülasyonları. TR201000948A1 (tr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2010/00948A TR201000948A1 (tr) 2010-02-09 2010-02-09 Aripiprazol formülasyonları.
PL11153639T PL2359816T3 (pl) 2010-02-09 2011-02-08 Formulacje aripiprazolu
EP11153639.7A EP2359816B1 (en) 2010-02-09 2011-02-08 Aripiprazole formulations
ES11153639.7T ES2607440T3 (es) 2010-02-09 2011-02-08 Formulaciones de aripiprazol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/00948A TR201000948A1 (tr) 2010-02-09 2010-02-09 Aripiprazol formülasyonları.

Publications (1)

Publication Number Publication Date
TR201000948A1 true TR201000948A1 (tr) 2011-08-22

Family

ID=42551366

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/00948A TR201000948A1 (tr) 2010-02-09 2010-02-09 Aripiprazol formülasyonları.

Country Status (4)

Country Link
EP (1) EP2359816B1 (tr)
ES (1) ES2607440T3 (tr)
PL (1) PL2359816T3 (tr)
TR (1) TR201000948A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3753B1 (ar) 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
WO2013100878A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole
WO2013175508A2 (en) 2012-05-24 2013-11-28 Medreich Limited Stable pharmaceutical composition of aripiprazole
WO2015067313A1 (en) * 2013-11-07 2015-05-14 Synthon B.V. Orodispersible pharmaceutical compositions comprising aripiprazole

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030868A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
WO2006097344A1 (en) * 2005-03-17 2006-09-21 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
WO2006105798A2 (en) * 2005-07-11 2006-10-12 Nycomed Danmark Aps Benzimidazole formulation
US20070148100A1 (en) * 2005-09-15 2007-06-28 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
EP1808165A1 (en) * 2006-01-05 2007-07-18 Teva Pharmaceutical Industries Ltd Dry formulations of aripiprazole
WO2008020820A2 (en) * 2006-08-15 2008-02-21 Nobel Ilac Sanayii Ve Ticaret A.S. Pharmaceutical compositions comprising aripiprazole
EP2082735A1 (en) * 2008-01-23 2009-07-29 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
MY129350A (en) 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution
JP4310605B2 (ja) 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
US20090198059A1 (en) 2004-09-13 2009-08-06 Chava Satyanarayana Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts
WO2006053781A1 (en) 2004-11-18 2006-05-26 Synthon B.V. Process of making crystalline aripiprazole
WO2007113846A1 (en) 2006-04-03 2007-10-11 Alembic Limited A process for the preparation of aripiprazole
EP1880714A1 (en) 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof
WO2010079506A2 (en) * 2008-06-23 2010-07-15 Torrent Pharmaceuticals Ltd. Pharmaceutical composition of aripiprazole

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003030868A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
WO2006097344A1 (en) * 2005-03-17 2006-09-21 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
WO2006105798A2 (en) * 2005-07-11 2006-10-12 Nycomed Danmark Aps Benzimidazole formulation
US20070148100A1 (en) * 2005-09-15 2007-06-28 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
EP1808165A1 (en) * 2006-01-05 2007-07-18 Teva Pharmaceutical Industries Ltd Dry formulations of aripiprazole
WO2008020820A2 (en) * 2006-08-15 2008-02-21 Nobel Ilac Sanayii Ve Ticaret A.S. Pharmaceutical compositions comprising aripiprazole
EP2082735A1 (en) * 2008-01-23 2009-07-29 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof

Also Published As

Publication number Publication date
ES2607440T3 (es) 2017-03-31
EP2359816A1 (en) 2011-08-24
PL2359816T3 (pl) 2017-04-28
EP2359816B1 (en) 2016-09-21

Similar Documents

Publication Publication Date Title
MX2020005181A (es) Derivados de aminopiridina como inhibidores de cinasas de la familia de tyro3, axl y mer (tam).
MY163083A (en) Solid forms of a pharmaceutically active substance
EP4345100A3 (en) Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
GEP201706671B (en) Heterocyclyl compounds as mek inhibitors
MX348823B (es) Formulaciones estables de linaclotida.
IL220863A (en) Oxazole derivatives of kinase inhibitors, medicinal preparations containing them and their uses
EP4606434A3 (en) Deuterated derivatives of ruxolitinib
MX2021011906A (es) Composiciones de liberacion retardada de linaclotida.
PH12015501096A1 (en) Composition for immediate and extended release
MY180165A (en) Heteroaryl butanoic acid derivatives as lta4h inhibitors
PH12014502294A1 (en) Triazolo compounds as pde10 inhibitors
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
MX2016003522A (es) Derivados de quinazolinas y su uso como inhibidores de la adn metiltransferasa.
AU2016204294A1 (en) Solid State Forms Of A Quinazoline Derivative And Its Use As A BRAF Inhibitor
TR201000948A1 (tr) Aripiprazol formülasyonları.
MX2013012918A (es) Formulaciones de liberacion sostenida de paracetamol.
AU2013338098A8 (en) Solid salt form of alpha-6-mPEG6-O-hydroxycodone as opioid agonists and uses thereof
IN2015DN02296A (tr)
UA116994C2 (uk) Стабілізована аморфна форма агомелатину, спосіб її одержання і фармацевтичні композиції, які її містять
TR201007926A1 (tr) Prasugrel tablet formülasyonları.
BR112013027391A2 (pt) formulação farmacêutica, frasco e kit
IN2013MU03309A (tr)
IN2013MU03422A (tr)
TR201009399A2 (tr) Hızlı çözünen efervesan rosuvastatin formülasyonları.
CY1117356T1 (el) Νεα μεθοδος συνθεσης της ιβαβραδινης και των αλατων προσθηκης της με ενα φαρμακευτικως αποδεκτο οξυ